BioCentury
ARTICLE | Company News

Galapagos, GlaxoSmithKline deal

June 23, 2008 7:00 AM UTC

Galapagos received a €800,000 ($1.2 million) milestone payment from GlaxoSmithKline under a 2006 deal that gave the pharma an option to license osteoarthritis compounds discovered by Galapagos followi...